in the
group of 522 men of Tatar
ethnic origin
from the Republic of Bashkortostan, Russia (213 patients
Zaplakhova, O. V.,
Nasibullin, T. R.,
Tuktarova, I. A.,
Timasheva, Y. R.,
Erdman, V. V.,
Bakhtiyarova, K. Z.,
Mustafina, O. E. (2018) . Both samples were formed from the
ethnic group of Russians. The results of the investigation
8, CCL16, CCL17, CCL18, CXCL1, CXCL8,
CXCL13, CCR2, CCR5, CXCR2, CXCR4, CX3CR1, CCL23) in the
groupANATOMIC MESOHEPATECTOMY VERSUS EXTENDED HEPATECTOMY FOR PATIENTS WITH CENTRALLY LOCATED HEPATOCELLULAR CARCINOMA for these patients by multivariable regression analysis. In addition, the patients in the MH
group were matched in a
CONNORS, J.M.,
SAVAGE, K.J,
JURCZAK, W,
LECH-MARANDA, E.,
SMOLEWSKI, P,
WALEWSKI, J,
STRAUS, D.J.,
YOUNES, A.,
ANSELL, S.M.,
KIM, W.S.,
GALLAMINI, A.,
ALEKSEEV, S.,
ILLÉS, A.,
ROSTA, A.,
PICARDI, M.,
ZINZANI, P.L.,
OKI, Y.,
FELDMAN, T.,
BARTLETT, N.L.,
CHEN, R.,
RAMCHANDREN, R.,
CUNNINGHAM, D.,
RADFORD, J.,
JOSEPHSON, N.C.,
SONG, E.,
SACHS, J.,
JOLIN, H.A.,
HUEBNER, D.,
LIU, R.,
LIPATOV, O.N. (2018) modified progression-free survival rates
in the A+AVD and ABVD
groups were 82.1% (95% confidence interval
Salimova, E.V.,
Mamaev, A.G.,
Tret'yakova, E. V.,
Kukovinets, O. S.,
Mavzyutov, A. R.,
Shvets, K. Yu.,
Parfenova, L. V. (2018) of addition of two cyanoethyl
groups to the -position with respect to the C-3=O carbonyl
group. The isolated